Request appointment
12902 USF Magnolia DriveTampa, FL 33612
Overview of Dr. Puri
Dr. Sonam Puri is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute, Huntsman Cancer Hospital, and University of Utah Health. She received her medical degree from Pt. B.D. Sharma Postgrad Institute of Medical Science and has been in practice 15 years. She is one of 12 doctors at Huntsman Cancer Hospital and one of 66 doctors at University of Utah Health who specialize in Oncology. She has more than 60 publications and over 500 citings.
Education & Training
University of ConnecticutResidency, Internal Medicine, 2013 - 2016
Pt. B.D. Sharma Postgrad Institute of Medical ScienceClass of 2011
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology
Certifications & Licensure
FL State Medical License 2024 - 2028
UT State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC Start of enrollment: 2022 Oct 10
Roles: Contact, Principal Investigator
- Tumor Treating Fields for Locally Advanced NSCLC Start of enrollment: 2024 Apr 04
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- ACR Appropriateness Criteria® Indolent Lung Cancer., Subba R Digumarthy, Brandon Messick, Christopher M Walker, Brent P Little
Journal of the American College of Radiology. 2026-08-10 - Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.Sonam Puri, Nofisat Ismaila, Ibrahim Hanna Azar, Janet Freeman-Daily, Naoki Furuya
Journal of Clinical Oncology. 2026-06-29 - Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1.Joshua E Reuss, Nofisat Ismaila, Amith Ahluwalia, Toby Campbell, Jill Feldman
Journal of Clinical Oncology. 2026-06-20
Press Mentions
Living Guideline Adds Repotrectinib and Zongertinib as Treatment Options for Advanced NSCLC with Driver AlterationsJuly 29th, 2026- FDA OKs New Keytruda Shot for CancerSeptember 19th, 2025
- Sonam Puri, MDJuly 15th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
